| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $27K | +21.8% |
| Operating Income | -$1.7M | +81.2% |
| Income Tax | $0 | — |
| Net Income | -$4.2M | +60.4% |
| EPS (Basic) | -$9.92 | +61.0% |
| EPS (Diluted) | -$9.92 | +61.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.1M | -7.7% |
| Current Assets | $23.1M | -7.7% |
| Total Assets | $28.1M | -6.4% |
| Current Liabilities | $582K | -25.2% |
| Total Liabilities | $43.3M | +5.5% |
| Stockholders' Equity | -$15.3M | -37.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.9M | +68.7% |
| Financing Cash Flow | $0 | -100.0% |